Skip to main content

5 Common Stock Valuation Myths

Valuation attracts myths the way honey attracts flies. Some myths are so deeply embedded in investing culture that seasoned professionals repeat them without questioning. Others are intuitive falsehoods that feel true even when data contradicts them. These myths lead investors to make systematic errors: overpaying for narrative, underpaying for value, and missing opportunities hiding in plain sight.

This article dissects five of the most damaging myths about stock valuation. Some will surprise you. Others you may have believed yourself. The point isn't to ridicule anyone for holding them—these myths persist because they contain fragments of truth, twisted into falsehood by oversimplification.

Quick Definition​

Valuation myths are widely accepted beliefs about how stocks are valued and how investors should approach valuation, which contradict empirical evidence or logical analysis. They persist because they're intuitive, socially reinforced, or derived from partial truths taken out of context.

Key Takeaways​

  • Low P/E ratios don't automatically indicate undervaluation; they often signal genuine risk or structural decline.
  • Valuation isn't more objective or scientific than stock picking; both require judgment about unknowable futures.
  • Popular stocks aren't overvalued simply because they're popular; sometimes consensus is correct.
  • You can't grow your way out of excessive valuation multiples without extraordinary performance over decades.
  • Valuation models don't eliminate uncertainty; they formalize it, sometimes creating false confidence about precision.

Myth 1: A Low P/E Ratio Means a Stock is Undervalued​

This is perhaps the most seductive myth in investing. You search for stocks with low price-to-earnings ratios. You find one trading at 8x earnings while the market average is 16x. Conclusion: the stock is undervalued. This logic is flawed, and understanding why is critical to avoiding value traps.

A P/E ratio is a price you're paying (numerator) divided by annual earnings (denominator). A low P/E means you're paying less per dollar of current earnings. But earnings aren't constant; they grow or shrink. If a stock has a low P/E because investors expect earnings to decline, then the low P/E is appropriate, not attractive.

The earnings yield matters more than the P/E ratio. If a stock trades at 8x earnings, its earnings yield is 12.5% (1 ÷ 8). That sounds great—a 12.5% return on your investment. Except it's not a return if earnings decline. If earnings fall 50% next year, the earnings yield was a mirage.

The investor who buys a low P/E stock is betting that the market has mispriced the earnings decay. Perhaps management has already addressed the problem. Perhaps the competitive disadvantage is temporary. Perhaps the balance sheet is fortress-like and can fund turnaround investments. These are bets. The low P/E ratio alone doesn't validate them.

Conversely, a high P/E ratio doesn't signal overvaluation if earnings are accelerating. Amazon traded at 100x+ earnings in the 1990s and 2000s because the market correctly anticipated explosive earnings growth. Investors who avoided Amazon because of its high P/E missed one of history's greatest wealth creators.

The myth persists because simple metrics are comforting. You don't have to forecast earnings or understand the business. You just screen for low multiples. But this simplicity comes at a cost: you're ignoring the reason the multiple is low. Smart investors pair multiple analysis with research into earnings momentum, competitive position, and balance sheet health. The multiple is a starting point, not a conclusion.

Myth 2: Valuation is a Science; Stock Picking is an Art​

This myth divides the financial world. "Valuation is quantitative and objective," believers say. "Stock picking is qualitative and subjective. Stick with valuation models." The distinction is false and dangerous.

Valuation requires just as much judgment as stock picking. Every valuation model begins with assumptions: What is the discount rate? What is terminal growth? What are margins in steady state? These aren't discovered in data; they're chosen based on judgment about unknowable futures.

Two analysts can run identical valuation models with different assumptions and reach opposite conclusions. Their models are equally rigorous. Their answers differ because they disagree about what the future will look like. That disagreement is not a mathematical disagreement; it's a judgment disagreement. One thinks the company will maintain 8% margins; the other thinks 12%. Both are reasonable. The difference in assumptions drives wildly different valuations.

The appearance of objectivity comes from the numbers. A discounted cash flow model produces a precise output: $47.32 per share. That precision suggests scientific rigor. But the output's precision is false precision if the inputs (discount rate, growth rate) are judgments, not facts. You've quantified your judgment, but you haven't made judgment more objective.

Empirical research backs this up. Studies comparing professional valuations to market prices show that valuation models explain only about 40–60% of price variation. The rest is driven by psychology, narrative, and factors the models don't capture. If valuation were truly a science, this explanatory power would be much higher. The fact that it's not tells us that subjective factors matter enormously.

The inverse of this myth is equally dangerous: "Valuation is just opinion, so my opinion is as good as anyone's." No. Valuation frameworks discipline thinking in ways that pure opinion doesn't. A DCF model forces you to be explicit about assumptions. You have to commit to a discount rate and defend it. You can't hedge and waffle. The discipline improves judgment, even though judgment remains at the core.

The truth: valuation and stock picking are both frameworks for applying judgment to uncertain information. Valuation frameworks are more structured, which helps, but they don't eliminate judgment. Using valuation models well means treating them as thinking tools, not oracles. You update assumptions as facts change. You test sensitivity to key drivers. You remain epistemically humble about precision.

This myth appeals to contrarian sensibilities. If everyone loves a stock, it must be overvalued. If everyone hates it, it must be undervalued. This appeals to the value investor's skepticism of consensus. But it conflates unpopularity with mispricing.

Sometimes popular stocks are overvalued. During the dot-com bubble, everyone loved internet companies, and they were insanely overvalued. But not always. During the late 1990s, investors loved Microsoft, Intel, and Cisco. Were they overvalued? Yes, somewhat. But were they terrible investments? No. These companies delivered decades of returns that justified even their bubble-era valuations.

More importantly: sometimes consensus is correct. Apple in 2010 was popular because it deserved to be popular. It had disrupted phones, tablets, and music. Its margins were exceptional. Its growth was real. Popular companies with genuine competitive advantages deserve high valuations. The market wasn't wrong about Apple; it was rational.

Conversely, unpopular stocks aren't inherently undervalued. Sometimes unpopular stocks are hated because the business is genuinely deteriorating. Print newspaper companies were unpopular in 2005 and 2010—with good reason. The digital disruption was real. Investors who bought "cheap" newspaper stocks betting on mean reversion lost money. Unpopularity was a signal, not a mispricing.

The contrarian instinct isn't wrong—true value opportunities often live in unpopular stocks. But unpopularity alone doesn't prove mispricing. You still have to do the analysis. Is the stock unpopular because the market has misjudged it, or because the market has correctly recognized a structural problem? These are different things.

Research on this is mixed. Some studies suggest extreme unpopularity (very low valuations) predicts outperformance. But the effect is modest and inconsistent. You'll beat the market sometimes by buying most hated, and you'll lose sometimes. The only way to know is to analyze the specific situation.

The myth persists because it flatters contrarians. It suggests that outsider skepticism is always rewarded. In reality, most unpopular stocks are unpopular for reasons. Some of those reasons are rational; some are emotional herd effects. Your job is to distinguish between them.

Myth 4: High Growth Can Justify Any Valuation Multiple​

This myth tempts growth investors constantly. A company is growing revenue at 50% annually. It's unprofitable now, but it will eventually be profitable and will maintain reasonable margins. So it can justify a high valuation today, right?

The math says no. Even extraordinary growth eventually ends. A company can't grow faster than the economy forever. At some point, it matures. When it does, valuation multiples compress.

Let's do the math. Assume a company with zero earnings today grows at 50% annually for 10 years. Then it drops to 2% growth (GDP growth) forever. Assume margins eventually reach 10% on revenues and the discount rate is 10%. What's the valuation today?

The company compounds revenues at 50% for 10 years, reaching roughly 50x the initial level. If today's revenues are $100 million, in 10 years they're $5 billion. With 10% margins, that's $500 million in annual earnings. At 10x earnings (assuming valuation multiples compress significantly), the company is worth roughly $5 billion. Discounting that back 10 years at 10% gives a present value of about $1.9 billion.

If the company has a $10 billion valuation today (which isn't unusual for high-growth tech), then you're implying even more growth—or higher terminal margins, or lower discount rates. You're very dependent on the high growth continuing exactly as expected. Any disappointment—a slowdown to 40% growth instead of 50%, margins that stay at 8% instead of reaching 10%—significantly impairs the return.

This is why high-growth valuations are fragile. They're not wrong if the growth materializes. But they leave no room for error. A mature company trading at 15x earnings can miss growth expectations and still be reasonably valued. A high-growth company trading at 50x sales can miss expectations and be cut in half.

Yet this isn't an argument that high valuations are always wrong. Companies like Netflix, Tesla, and Amazon at various points in their early growth were expensive by every metric. But they delivered the growth, and shareholders were rewarded. The risk was real; the reward was also real.

The myth is the assumption that high growth automatically justifies high valuation. It doesn't. The valuation is justified only if the growth materializes consistently and the company eventually becomes profitable with acceptable margins. Those are big ifs.

Myth 5: Valuation Models Remove Emotion and Uncertainty​

This myth is especially popular among finance students and new analysts. "I'll build a comprehensive DCF model," the thinking goes. "Then I'll have an objective fair value I can rely on, free from emotional bias." The model becomes a security blanket against uncertainty.

But models don't eliminate uncertainty; they formalize it. A DCF model takes your uncertainty about future cash flows, future discount rates, and terminal value and wraps it in equations. The output looks precise: $47.32. But the precision is illusory. Change the discount rate from 8% to 9%, and the value drops to $42. Change terminal growth from 3% to 2%, and it drops again. The model hasn't reduced uncertainty; it's just made assumptions explicit.

This can be valuable. Explicit assumptions are better than implicit ones. You can see what's driving the valuation. You can test sensitivity. But this clarity of process is different from certainty about outcome. Many analysts mistake the former for the latter.

Worse, detailed models create overconfidence. A 60-page valuation with tables, charts, and multiple scenarios looks authoritative. Readers assume the analyst has reduced uncertainty through rigor. In reality, the analyst has quantified uncertainty and sometimes underestimated its magnitude. The production value of the model exceeds its predictive power.

This is why experienced analysts often prefer simple models with transparent assumptions to complex models that hide assumptions in layers of calculation. A simple DCF that says "fair value is $40–$60 depending on growth assumptions" is more honest than a complex model that says "fair value is $47.32." Both are guesses about the future. The simple model admits it; the complex model disguises it.

The emotion still exists. It's just moved from the decision step (should I buy?) to the assumption step (what growth should I assume?). You can be emotionally attached to a rosy revenue projection. A detailed model doesn't make you less emotionally attached; it legitimizes the attachment with calculations.

Professional investors compensate for this by using models as thinking tools, not decision tools. The model is a framework for organizing your thoughts about the future, not a crystal ball. You update assumptions constantly. You test them against history and against other companies. You remain skeptical of precision. And you use the model as context for judgment, not a replacement for it.

Real-World Examples​

Cisco Systems (2000–2010): Cisco traded at over 100x earnings in 2000 because the internet was supposedly going to transform everything. The internet did transform things, but not as dramatically or as quickly as expected. Cisco's growth slowed. Its valuation compressed. Investors who bought at the peak valuation lost money despite Cisco remaining a good company. The valuation was the problem, not the business.

Target (2013–2019): Target traded at modest valuations throughout this period, and the stock returned only about 5% annually. Meanwhile, other retailers with higher valuations returned more. The low valuation reflected real risks: digital disruption from Amazon, execution challenges, margin compression. The market wasn't wrong about the risks. Investors who bought cheap expecting mean reversion were disappointed.

Netflix (2012–2018): Netflix grew subscribers and revenues at enormous rates throughout this period. Yet the stock didn't compound as fast as revenue because valuation multiples expanded (but not as much as growth accelerated). Investors expected even more growth. The valuation was high relative to earnings (Netflix was still unprofitable), but not relative to the growth that materialized. The model worked because Netflix delivered the goods.

Common Mistakes​

Comparing multiples across industries: Tech stocks trade at higher P/E ratios than utilities because they have higher growth rates. Comparing them directly and concluding tech is overvalued is a mistake. You have to adjust for growth. Industry comparison makes sense only within an industry with similar growth profiles.

Using trailing earnings instead of normalized earnings: A company had a bad year and reported low earnings. So its P/E ratio is super low. But if you expect normal earnings to resume, the low P/E is misleading. Use the normalized earnings, not the trough earnings. A one-time charge that reduced earnings artificially is not a signal about valuation.

Ignoring the risk side of the discount rate: Some investors use a discount rate based only on interest rates. But discount rates should reflect both risk-free rates and company-specific risk. A distressed company should have a higher discount rate than a stable company. This risk adjustment directly impacts valuation. Ignore it, and you overpay for risk.

Confusing cash flow with earnings: Some companies grow earnings faster than cash flow because they require heavy capital investment or extend payment terms to customers. Valuation should be based on cash flow, not accounting earnings. A company generating high earnings but low cash flow may be destroying value, not creating it.

Treating multiples as permanent: Companies and industries change. Multiples that were appropriate in a previous era may not be appropriate now. Utilities used to trade at 15x earnings and now trade at 12x. That doesn't mean they're undervalued at 12x; it means the interest rate environment and dividend policy have changed.

FAQ​

Q: If P/E ratios are misleading, what multiple should I use?

A: Price-to-book, price-to-sales, and price-to-free-cash-flow are alternatives, each useful in different contexts. None is perfect. Price-to-book works for asset-heavy businesses but misleads for asset-light businesses. Price-to-sales is stable but ignores profitability. Price-to-cash-flow is theoretically sound but volatile. Use multiple metrics and triangulate. Don't rely on any single multiple.

Q: Can a valuation model ever be truly objective?

A: No, not if the company's future is uncertain (which it always is). What you can do is make your subjective assumptions explicit and repeatable. That's disciplined. But it's not objective in the way physics is objective. Human judgment is always involved.

Q: How do I know if a valuation myth is actually true?

A: Look for empirical research. Has someone tested whether low P/E stocks outperform? (Yes, somewhat, but with many caveats.) Has someone tested whether high-growth stocks justify their valuations? (Yes, and the evidence is mixed.) Read critically. Look for sample bias, time period bias, and survivorship bias in the research. Then make your own judgment.

Q: Is it better to use a simple valuation model or a complex one?

A: Simple, with caveats. Simpler models make assumptions clearer and force you to be more parsimonious about what drives value. Complex models can hide assumptions or give false precision. But in some cases (a business with multiple revenue streams, complex capital structure), more detail is necessary. The rule: use as much complexity as you need to capture the business reality, but no more.

Q: Should I ever buy a stock that valuation models say is overvalued?

A: Yes, sometimes. If you have a strong conviction that the model's assumptions are too conservative, then the valuation might be a bargain despite the model saying otherwise. Or you might have information about management or competitive position that the model doesn't capture. But this should be an exception, not a rule. Most of the time, if your valuation model says a stock is expensive, it probably is.

Q: Do Wall Street analysts perpetuate these myths?

A: Often. Analysts have incentives to believe myths. If you believe low P/E stocks are undervalued, you'll recommend cheap stocks. If you believe high growth justifies any valuation, you'll cover high-growth companies. Analysts are also subject to the same cognitive biases as everyone else. They're not immune to myths just because they're professionals.

Summary​

Valuation myths persist because they contain seeds of truth distorted by oversimplification. A low P/E ratio is worth investigating, but it's not proof of undervaluation. Valuation frameworks are more structured than pure stock picking, but they're not objective—they're disciplined judgment applied to uncertainty. Unpopular stocks sometimes offer value, but unpopularity isn't proof of opportunity. High growth can justify high valuations, but only if growth materializes. And models formalize uncertainty; they don't eliminate it.

The antidote to these myths is critical thinking. Take the conventional wisdom, test it against evidence, and build your own understanding. Most myths persist not because they're entirely false but because they're simpler than the truth. The truth is more nuanced: valuation is a messy combination of framework and judgment, discipline and skepticism, analysis and narrative. When you accept that complexity, you stop searching for myths to believe and start building genuine understanding.

Next​

Read Numbers vs. Narrative: The Valuation Gap to understand how stories reshape the numbers and drive real valuation outcomes.